Immunosuppressive therapy in primary glomerulonephritides (concluding remarks).
D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000150:complications; D011507:Proteinuria / Q000150:complications
D007166:Immunosuppressive Agents